Cancer Cell. 2009 Mar 3;15(3):232-9.

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS.

Source

Molecular and Cellular Biology Research, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.

Abstract

Herein we report that the VEGFR/PDGFR kinase inhibitor sunitinib/SU11248 can accelerate metastatic tumor growth and decrease overall survival in mice receiving short-term therapy in various metastasis assays, including after intravenous injection of tumor cells or after removal of primary orthotopically grown tumors. Acceleration of metastasis was also observed in mice receiving sunitinib prior to intravenous implantation of tumor cells, suggesting possible "metastatic conditioning" in multiple organs. Similar findings with additional VEGF receptor tyrosine kinase inhibitors implicate a class-specific effect for such agents. Importantly, these observations of metastatic acceleration were in contrast to the demonstrable antitumor benefits obtained when the same human breast cancer cells, as well as mouse or human melanoma cells, were grown orthotopically as primary tumors and subjected to identical sunitinib treatments.

Comment in

PMID:: 19249681; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

PYRROLE - HSDB

Supplemental Content

Related citations

Review Sunitinib: a newly approved small-molecule inhibitor of angiogenesis. [Drugs Today (Barc). 2006]
Review Sunitinib: a newly approved small-molecule inhibitor of angiogenesis.
Cabebe E, Wakelee H. Drugs Today (Barc). 2006 Jun; 42(6):387-98.
Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors. [Clin Cancer Res. 2009]
Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
Castillo-Avila W, Piulats JM, Garcia Del Muro X, Vidal A, Condom E, Casanovas O, Mora J, Germà JR, Capellà G, Villanueva A, et al. Clin Cancer Res. 2009 May 15; 15(10):3384-95. Epub 2009 May 5.
Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma. [Curr Cancer Drug Targets. 2009]
Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma.
Huynh H, Ngo VC, Choo SP, Poon D, Koong HN, Thng CH, Toh HC, Zheng L, Ong LC, Jin Y, et al. Curr Cancer Drug Targets. 2009 Sep; 9(6):738-47.
Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma. [Neuro Oncol. 2007]
Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.
de Boüard S, Herlin P, Christensen JG, Lemoisson E, Gauduchon P, Raymond E, Guillamo JS. Neuro Oncol. 2007 Oct; 9(4):412-23. Epub 2007 Jul 10.
Review Sunitinib. [Expert Opin Pharmacother. 2007]
Review Sunitinib.
Rini BI. Expert Opin Pharmacother. 2007 Oct; 8(14):2359-69.

See reviews... See all...

Cited by 97 PubMed Central articles

Epithelial mesenchymal transition and lung cancer. [J Thorac Dis. 2010]
Epithelial mesenchymal transition and lung cancer.
Xiao D, He J. J Thorac Dis. 2010 Sep; 2(3):154-9.
Notch: a key regulator of tumor angiogenesis and metastasis. [Histol Histopathol. 2012]
Notch: a key regulator of tumor angiogenesis and metastasis.
Garcia A, Kandel JJ. Histol Histopathol. 2012 Feb; 27(2):151-6.
Angiogenesis in head and neck cancer: a review of the literature. [J Oncol. 2012]
Angiogenesis in head and neck cancer: a review of the literature.
Carla C, Daris F, Cecilia B, Francesca B, Francesca C, Paolo F. J Oncol. 2012; 2012:358472. Epub 2011 Nov 10.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Accelerated metastasis after short-term treatment with a potent inhibitor of tum...
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.
Cancer Cell. 2009 Mar 3 ;15(3):232-9.

PubMed
Systematic and single cell analysis of Xenopus Piwi-interacting RNAs and Xiwi.
Systematic and single cell analysis of Xenopus Piwi-interacting RNAs and Xiwi.
EMBO J. 2009 Oct 7 ;28(19):2945-58. Epub 2009 Aug 27 .

PubMed
Cooked meat and risk of breast cancer--lifetime versus recent dietary intake.
Cooked meat and risk of breast cancer--lifetime versus recent dietary intake.
Epidemiology. 2007 May ;18(3):373-82.

PubMed
A pilot randomised, open, uncontrolled, clinical study of two dosages of St John...
A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation.
Planta Med. 2006 Mar ;72(4):378-82.

PubMed
Liposarcoma: outcome based on the Scandinavian Sarcoma Group register.
Liposarcoma: outcome based on the Scandinavian Sarcoma Group register.
Cancer. 2008 Oct 1 ;113(7):1649-56.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: